학술논문
Randomized, double-blind, phase III trial of palonosetron versus granisetron in the triplet regimen for preventing chemotherapy-induced nausea and vomiting after highly emetogenic chemotherapy: TRIPLE study
Document Type
Article
Author
Source
In Annals of Oncology August 2016 27(8):1601-1606
Subject
Language
ISSN
0923-7534